prednisolone has been researched along with Benign Supratentorial Neoplasms in 4 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the safety and efficacy of postoperative hyperfractionated concomitant boost proton radiotherapy with nimustine hydrochloride for supratentorial glioblastoma multiforme (GBM)." | 5.14 | Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme. ( Hashii, H; Hayashi, Y; Igaki, H; Kanemoto, A; Matsumura, A; Mizumoto, M; Nakayama, H; Oshiro, Y; Sakurai, H; Sugahara, S; Takano, S; Tokuuye, K; Tsuboi, K; Yamamoto, T, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mizumoto, M | 1 |
| Tsuboi, K | 1 |
| Igaki, H | 1 |
| Yamamoto, T | 1 |
| Takano, S | 1 |
| Oshiro, Y | 1 |
| Hayashi, Y | 1 |
| Hashii, H | 1 |
| Kanemoto, A | 1 |
| Nakayama, H | 1 |
| Sugahara, S | 1 |
| Sakurai, H | 1 |
| Matsumura, A | 1 |
| Tokuuye, K | 1 |
| KOFMAN, S | 1 |
| GARVIN, JS | 1 |
| NAGAMANI, D | 1 |
| TAYLOR, SG | 1 |
| Ducray, F | 1 |
| Colin, P | 1 |
| Cartalat-Carel, S | 1 |
| Pelissou-Guyotat, I | 1 |
| Mahla, K | 1 |
| Audra, P | 1 |
| Gaucherand, P | 1 |
| Honnorat, J | 1 |
| Trouillas, P | 1 |
| Guenther, PP | 1 |
| Huebner, A | 1 |
| Sobottka, SB | 1 |
| Neumeister, V | 1 |
| Weissbach, G | 1 |
| Todt, H | 1 |
| Parwaresch, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Restrictive Use of Dexamethasone in Glioblastoma[NCT04266977] | 50 participants (Anticipated) | Interventional | 2020-05-08 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for prednisolone and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
Topics: Adult; Aged; Antineoplastic Agents; Combined Modality Therapy; Dexamethasone; Dose Fractionation, Ra | 2010 |
3 other studies available for prednisolone and Benign Supratentorial Neoplasms
| Article | Year |
|---|---|
Treatment of cerebral metastases from breast carcinoma with prednisolone.
Topics: Brain; Brain Neoplasms; Breast Neoplasms; Humans; Prednisolone; Supratentorial Neoplasms | 1957 |
[Management of malignant gliomas diagnosed during pregnancy].
Topics: Abortion, Therapeutic; Adrenal Cortex Hormones; Adult; Algorithms; Anesthesia, General; Antineoplast | 2006 |
Temporary response of localized intracranial mast cell sarcoma to combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cranial Irradiatio | 2001 |